IQVIA (IQV)
(Real Time Quote from BATS)
$212.65 USD
+3.71 (1.78%)
Updated Jul 9, 2024 01:16 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Price, Consensus and EPS Surprise
IQV 212.65 +3.71(1.78%)
Will IQV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IQV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IQV
Clinical Development Expertise Aids IQVIA (IQV), Costs High
Paychex (PAYX) to Report Q4 Earnings: What's in the Offing?
IQV: What are Zacks experts saying now?
Zacks Private Portfolio Services
EPAM Expands in Life Sciences Space With Odysseus Buyout
IQVIA (IQV) Announces Launch of Trial Technology Platform
Here's Why You Should Hold on to IQVIA (IQV) Stock for Now
Other News for IQV
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
Barclays Keeps Their Buy Rating on IQVIA Holdings (IQV)
Iqvia price target lowered by $20 at Barclays, here's why
5 Analysts Assess IQVIA Hldgs: What You Need To Know
Goldman’s top 50 high Sharpe Ratio stocks